Research map: TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo

Back to the article

Papers in this map

  1. fastp: an ultra-fast all-in-one FASTQ preprocessor · Shifu Chen · 2018 · 31731 citations · Cited by this paper
  2. Diabetic and ER-stressed pancreatic islet β cells are in need of some JNK removal · Jonathan M. Palozzi · 2026 · Related
  3. Salmon provides fast and bias-aware quantification of transcript expression · Rob Patro · 2017 · 14229 citations · Cited by this paper
  4. A peripheral subpopulation of retinal pigment epithelium resists oxidative damage through SERPINE3-mediated Caspase-1 inhibition · 2026 · Related
  5. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics · Shao‐En Ong · 2002 · 5659 citations · Cited by this paper
  6. Sterol biosynthesis, brain development, and disease · 2026 · Related
  7. The regulation of IL-10 production by immune cells · Margarida Saraiva · 2010 · 3201 citations · Cited by this paper
  8. S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via non-canonical SREBP2 signaling · 2026 · Related
  9. Identification and characterization of a new member of the TNF family that induces apoptosis · Steven R. Wiley · 1995 · 2919 citations · Cited by this paper
  10. Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment · 2026 · Related
  11. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo · Henning Walczak · 1999 · 2521 citations · Cited by this paper
  12. Protein neddylation as a therapeutic target: challenges and opportunities · 2026 · Related
  13. The immune contexture in cancer prognosis and treatment · Wolf H. Fridman · 2017 · 2375 citations · Cited by this paper
  14. Winners of Lasker Foundation Video Contest announced · 2026 · Related
  15. Safety and antitumor activity of recombinant soluble Apo2 ligand · Avi Ashkenazi · 1999 · 2235 citations · Cited by this paper
  16. The bone-cerebrovascular axis: effects of bone aging on neurovascular dysfunction and neurodegeneration · 2026 · Related
  17. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation · Jens Markus Chemnitz · 2004 · 1273 citations · Cited by this paper
  18. Histone lysine methyltransferases KMT2C and KMT2D join the all-star tumor suppressor team in gastrointestinal cancer · 2026 · Related
  19. Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5 · Frank Christian Kischkel · 2000 · 983 citations · Cited by this paper
  20. Arul M. Chinnaiyan, MD, PhD, and Charles L. Sawyers, MD, receive the 2026 Harrington Prize for Innovation in Medicine · 2026 · Related
  21. TRAIL and apoptosis induction by TNF-family death receptors · Shulin Wang · 2003 · 886 citations · Cited by this paper
  22. The TRAIL apoptotic pathway in cancer onset, progression and therapy · Ricky W. Johnstone · 2008 · 839 citations · Cited by this paper
  23. TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB · Pascal Schneider · 1997 · 700 citations · Cited by this paper
  24. PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients · Armida D’Incecco · 2014 · 610 citations · Cited by this paper
  25. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy · Silvia von Karstedt · 2017 · 568 citations · Cited by this paper
  26. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells · Saar I. Gill · 2014 · 502 citations · Cited by this paper
  27. ZAP-70 Deficiency in an Autosomal Recessive form of Severe Combined Immunodeficiency · Andrew C. Chan · 1994 · 496 citations · Cited by this paper
  28. Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade · Gordon James Freeman · 2006 · 402 citations · Cited by this paper
  29. Direct Regulation of ZAP-70 by SHP-1 in T Cell Antigen Receptor Signaling · David R. Plas · 1996 · 393 citations · Cited by this paper
  30. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells · Akiko Seki · 2018 · 391 citations · Cited by this paper
  31. Frequent expression of PD‐L1 on circulating breast cancer cells · Martine Mazel · 2015 · 377 citations · Cited by this paper
  32. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation · Sandrine Jouan-Lanhouet · 2012 · 363 citations · Cited by this paper
  33. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice · Salah-Eddine Lamhamedi-Cherradi · 2003 · 353 citations · Cited by this paper
  34. Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor · Liwei Chen · 2006 · 280 citations · Cited by this paper
  35. IFN-γ Mediates a Novel Antiviral Activity Through Dynamic Modulation of TRAIL and TRAIL Receptor Expression · Lisa M. Sedger · 1999 · 232 citations · Cited by this paper
  36. Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer · Jean‐Charles Soria · 2010 · 227 citations · Cited by this paper
  37. Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection · Elisabeth Amyes · 2003 · 224 citations · Cited by this paper
  38. Overall survival and PD‐L1 expression in metastasized malignant melanoma · Jules Gadiot · 2010 · 222 citations · Cited by this paper
  39. Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors Signal NF-κB and JNK Activation and Apoptosis through Distinct Pathways · Wenhui Hu · 1999 · 218 citations · Cited by this paper

Source: OpenAlex (CC0)